UBX | Unity Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	N/A	236.00K	4.78M	N/A	N/A	N/A	1.38M	N/A
Cost of Revenue	19.70M	2.18M	2.88M	3.45M	2.66M	2.18M	37.37M	153.00K
Gross Profit	-19.70M	-1.94M	1.90M	-3.45M	-2.66M	-2.18M	-35.99M	-153.00K
Operating Expenses	24.97M	57.81M	61.45M	91.33M	91.00M	74.92M	46.99M	18.84M
Selling, General & Admin	18.77M	20.95M	23.06M	24.02M	20.05M	16.02M	9.62M	5.14M
Research & Development	20.80M	36.86M	38.39M	67.31M	70.96M	58.91M	37.37M	13.71M
Other Operating Expenses	-14.60M	-17.00K	-983.00K	182.00K	4.18M	-245.00K	-103.00K	N/A
Operating Income	-44.67M	-57.57M	-56.66M	-93.93M	-89.65M	-79.47M	-45.61M	-18.84M
Other Expenses / Income	4.81M	13.10M	-4.06M	86.00K	7.47M	3.07M	952.00K	-11.56M
Before Tax Income	-39.86M	-59.93M	-60.73M	-93.84M	-82.18M	-76.40M	-44.66M	-30.40M
Income Tax Expenses	N/A	-2.18M	-686.00K	-1.98M	-7.30M	3.07M	-1.05M	11.56M
Net Income	-39.86M	-57.75M	-60.04M	-91.87M	-74.87M	-76.40M	-44.66M	-30.40M
Interest Expenses	N/A	3.56M	3.18M	1.29M	N/A	3.31M	N/A	N/A
Basic Shares Outstanding	14.77M	9.49M	5.58M	5.09M	4.36M	2.83M	343.73K	343.73K
Diluted Shares Outstanding	14.77M	9.49M	5.58M	5.09M	4.36M	2.83M	343.73K	343.73K
EBITDA	-37.28M	-38.73M	-54.67M	-89.10M	-89.65M	-74.22M	-44.30M	-28.07M
EBITDA Margin	0.00%	-16,411.44%	-1,142.73%	0.00%	0.00%	0.00%	-3,205.79%	0.00%
EBIT	-39.86M	-56.37M	-57.55M	-92.55M	-82.18M	-70.02M	-45.71M	-18.84M
EBIT Margin	0.00%	-23,885.17%	-1,202.93%	0.00%	0.00%	0.00%	-3,307.60%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31